Ultromics

Ultromics is an Oxford University spin-out developing AI-powered software that analyses routine echocardiogram images to detect complex cardiac conditions.

Its cloud-based platform holds multiple FDA clearances and CE marks for heart failure with preserved ejection fraction and cardiac amyloidosis screening.

The technology is deployed across NHS trusts and US healthcare systems including Mayo Clinic, and has raised over $135m in venture funding.